Core Insights - The latest "GEI China Unicorn Enterprises Research Report 2025" indicates that China's unicorn companies have entered a new stage of high-quality development, showcasing distinct characteristics of hard technology and innovation vitality [1] - By 2024, the number of unicorn companies in China reached 372, with a total valuation exceeding $1.2 trillion [1] Group 1: Seed Unicorn Enterprises - Seed unicorn enterprises are defined as newly established startups with high growth potential and technological innovation capabilities, possessing the potential to exceed a valuation of $1 billion [1] - These companies have core independent intellectual property rights and market competitiveness, aligning their main business and core technologies with national and local strategic development directions [1] - To support the development of seed unicorn enterprises, various policies and measures have been introduced by national and local governments to ensure sustainable growth [1] Group 2: Shenzhen Haichuang Biotechnology Co., Ltd. - Shenzhen Haichuang Biotechnology Co., Ltd. was awarded the title of "Seed Unicorn Enterprise" at the China (Shenzhen) Unicorn Enterprise Conference held in July 2025 [2] - The company focuses on strategic industries such as artificial intelligence, integrated circuits, and biomedicine, and is recognized for its innovative or disruptive technologies [2] - With over 30 years of research and development achievements, Haichuang has significant growth potential and innovation capabilities, currently aiming for a valuation of 100 billion [2][3] Group 3: Product Development and Innovation - Haichuang's brand "Haipuno" specializes in skin immune anti-aging products, supported by over 60 high-value patents and extensive clinical trial results [3] - The company has launched new products such as "95 Black Gold Essence" and "Award-Winning Eye Cream," with the latter winning the "APAAACI International Science and Technology Gold Award" in December 2024 [4] - The innovative ingredient HEPRO-GABA developed by Haipuno addresses common eye area issues, while HEPRO-6A enhances the immune cell's ability to eliminate aging cells [4][5] Group 4: Market Position and Future Plans - In a challenging economic environment, the skincare market is experiencing polarization, with brands lacking core R&D capabilities gradually exiting the market [4] - Haichuang has successfully completed two rounds of funding, indicating a market shift towards valuing core competitiveness over marketing prowess [5] - The company plans to develop a professional skincare line for children, with products targeting eczema set to launch in 2025 [5]